IFIH1 and Smith-Magenis syndrome: Future studies aiming at investigating the underlying mechanisms of MDA5 and RIG-I contributions to the pathogenesis of SMS and identifying other factors cross-talking with MDA5 and RIG-I signaling will be critical to develop therapeutic targets of MDA5 or RIG-I for SMS.